TRUE ANON TRUTH FEED Episode 533: Cuba 2
19 snips
Mar 25, 2026 Mitchell Valdés-Sosa, director of the Cuban Center for Neuroscience and a neuroscientist, reflects on Cuba’s research system and his path from Chicago to leading neuroscience there. He discusses Cuba’s Alzheimer’s drug efforts, how sanctions hinder science, and his scientific review of Havana Syndrome. The conversation stresses restoring international collaboration and practical impacts on Cuban healthcare and migration.
AI Snips
Chapters
Transcript
Episode notes
How Cuba Built Its Neuroscience Sector
- Cuba built a modern neuroscience and computing research base after 1959 by creating a National Research Center that incubated 30+ centers.
- Mitchell Valdés-Sosa explains Fidel pushed domestic tech like the CIT-201A after blocked US equipment donations.
Account For Sanctions When Partnering With Cuba
- Persistent U.S. sanctions block scientific collaboration by preventing spare parts, bank transfers, and investor engagement.
- Mitchell urges partners to weigh legal risk and seek cautious legal advice before joint projects with Cuban labs.
Cuba's Multipronged Alzheimer's Strategy
- Cuba pursues multiple dementia drug candidates simultaneously to avoid single-point failure in Alzheimer's research.
- Neuroep is intranasal, targets erythropoietin receptors to dampen inflammation and cell death, and is being trialed internationally.